At its CES exposition, AMD demonstrated its latest Instinct MI325X accelerator for AI and HPC workloads, which also happens ...

AI drug creation company Absci Corporation (NASDAQ:ABSI) shares are trading higher in premarket on Wednesday after the ...

Absci will use AMD’s $20 million investment to enhance its AI models. In parallel, the companies will collaborate to develop ...

Advanced Micro Devices shows bearish near-term signals but strong growth ahead. Learn why AMD stock could be an attractive ...

Absci Corporation (ABSI), a Washington-based biotechnology company, Wednesday has announced a strategic collaboration with AMD to ...

Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug creation company, today announced a strategic collaboration with AMD to deploy AMD Instinct™ accelerators and ROCm™ software to power ...

Absci Corporation (ABSI) announced a strategic collaboration with AMD (AMD) to deploy AMD Instinct accelerators and ROCm software to power critical AI drug discovery workloads, including Absci’s ...

Wednesday has announced a strategic collaboration with AMD to deploy AMD Instinct accelerators and ROCm software to support critical AI-driven drug discovery tasks, including Absci's advanced de ...

AMD makes a $20 million investment to boost drug research. The partnership will leverage AMD Instinct accelerators and ROCm software to support Absci’s advanced de novo antibody design models.

The partnership will leverage AMD Instinct accelerators and ROCm software to support Absci’s advanced de novo antibody design models. The deal also includes a $20 million private investment in ...